From cancer immunotherapy to diabetes and weight loss breakthroughs, 2025’s top-selling drugs highlight how pharmaceutical ...

A traumatic injury, such as whiplash from a car crash, can also cause pain, or, your pain could be the accumulation of a bad ...

Bayer has decided to discontinue a phase 3 trial of its oral Factor XIa inhibitor asundexian in patients with atrial fibrillation (AF), after an interim analysis concluded the novel anticoagulant ...

Following Keytruda, Bristol-Myers Squibb (BMS) and Pfizer's Eliquis (apixaban), an oral anticoagulant, will be the second best-selling drug out of the top ten, with annual sales of $18.7 billion ...

Mechanisms of disease articles from across Nature Portfolio The defects in molecular and cellular processes that constitute the triggers of specific pathologies are referred to as mechanisms of ...